A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen Anthony, DO
Sumitomo Pharma America, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Chicago
Chicago, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- Johns Hopkins
Baltimore, Maryland, United States
- Columbia University
New York, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Us Oncology - Texas Oncology - Austin Midtown
Austin, Texas, United States
- Us Oncology - Texas Oncology - Baylor University Medical Center
Dallas, Texas, United States
- Us Oncology - Texas Oncology - Fort Worth
Fort Worth, Texas, United States
- Us Oncology - Texas Oncology - San Antonio Medical Center
San Antonio, Texas, United States
- Us Oncology - Texas Oncology - Tyler
Tyler, Texas, United States
- Us Oncology - Virginia Cancer Specialists, Pc
Fairfax, Virginia, United States
- Us Oncology - Northwest Cancer Specialists, P.C.
Vancouver, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Aug 2018
- Primary completion
- 16 Aug 2021
- Completion
- 16 Aug 2021
- Last update posted
- 9 Nov 2023
- Registered enrollment
- 20
- Registry id
- NCT03593915
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.